<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE us-patent-application SYSTEM "us-patent-application-v43-2012-12-04.dtd" [ ]><us-patent-application lang="EN" dtd-version="v4.3 2012-12-04" file="US20140005400A1-20140102.XML" status="PRODUCTION" id="us-patent-application" country="US" date-produced="20131218" date-publ="20140102"><us-bibliographic-data-application lang="EN" country="US"><publication-reference><document-id><country>US</country><doc-number>20140005400</doc-number><kind>A1</kind><date>20140102</date></document-id></publication-reference><application-reference appl-type="utility"><document-id><country>US</country><doc-number>14013551</doc-number><date>20130829</date></document-id></application-reference><us-application-series-code>14</us-application-series-code><priority-claims><priority-claim sequence="01" kind="regional"><country>EP</country><doc-number>10172747.7</doc-number><date>20100813</date></priority-claim></priority-claims><classifications-ipcr><classification-ipcr><ipc-version-indicator><date>20060101</date></ipc-version-indicator><classification-level>A</classification-level><section>C</section><class>07</class><subclass>D</subclass><main-group>471</main-group><subgroup>10</subgroup><symbol-position>F</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source></classification-ipcr></classifications-ipcr><classifications-cpc><main-cpc><classification-cpc><cpc-version-indicator><date>20130101</date></cpc-version-indicator><section>C</section><class>07</class><subclass>D</subclass><main-group>471</main-group><subgroup>10</subgroup><symbol-position>F</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source><scheme-origination-code>C</scheme-origination-code></classification-cpc></main-cpc></classifications-cpc><classification-national><country>US</country><main-classification>546 16</main-classification></classification-national><invention-title id="d0e61">NEW AZACYCLIC COMPOUNDS</invention-title><us-related-documents><continuation><relation><parent-doc><document-id><country>US</country><doc-number>13204743</doc-number><date>20110808</date></document-id><parent-grant-document><document-id><country>US</country><doc-number>8552024</doc-number></document-id></parent-grant-document></parent-doc><child-doc><document-id><country>US</country><doc-number>14013551</doc-number></document-id></child-doc></relation></continuation></us-related-documents><us-parties><us-applicants><us-applicant sequence="00" app-type="applicant" designation="us-only" applicant-authority-category="assignee"><addressbook><orgname>Hoffmann-La Roche Inc.</orgname><address><city>Nutley</city><state>NJ</state><country>US</country></address></addressbook><residence><country>US</country></residence></us-applicant></us-applicants><inventors><inventor sequence="00" designation="us-only"><addressbook><last-name>Ackermann</last-name><first-name>Jean</first-name><address><city>Riehen</city><country>CH</country></address></addressbook></inventor><inventor sequence="01" designation="us-only"><addressbook><last-name>Conte</last-name><first-name>Aurelia</first-name><address><city>Basel</city><country>CH</country></address></addressbook></inventor><inventor sequence="02" designation="us-only"><addressbook><last-name>Hunziker</last-name><first-name>Daniel</first-name><address><city>Moehlin</city><country>CH</country></address></addressbook></inventor><inventor sequence="03" designation="us-only"><addressbook><last-name>Neidhart</last-name><first-name>Werner</first-name><address><city>Hagenthal-le-Bas</city><country>FR</country></address></addressbook></inventor><inventor sequence="04" designation="us-only"><addressbook><last-name>Nettekoven</last-name><first-name>Matthias</first-name><address><city>Grenzach-Wyhlen</city><country>DE</country></address></addressbook></inventor><inventor sequence="05" designation="us-only"><addressbook><last-name>Schulz-Gasch</last-name><first-name>Tanja</first-name><address><city>Ziefen</city><country>CH</country></address></addressbook></inventor><inventor sequence="06" designation="us-only"><addressbook><last-name>Wertheimer</last-name><first-name>Stanley</first-name><address><city>Croton</city><state>NY</state><country>US</country></address></addressbook></inventor></inventors></us-parties><assignees><assignee><addressbook><orgname>Hoffmann-La Roche Inc.</orgname><role>03</role><address><city>Nutley</city><state>NJ</state><country>US</country></address></addressbook></assignee></assignees></us-bibliographic-data-application><abstract id="abstract"><p id="p-0001" num="0000">The invention provides novel compounds having the general formula (I)</p><p id="p-0002" num="0000"><chemistry id="CHEM-US-00001" num="00001"><img id="EMI-C00001" he="18.29mm" wi="58.59mm" file="US20140005400A1-20140102-C00001.TIF" alt="embedded image" img-content="chem" img-format="tif"/></chemistry></p><p id="p-0003" num="0000">wherein R<sup>1</sup>, R<sup>2 </sup>and n are as described herein, compositions including the compounds and methods of using the compounds. The compounds are useful as inhibitors of hormone sensitive lipase (HSL) for the treatment of diabetes, metabolic syndrome and obesity.</p></abstract></us-patent-application>